thalidomide peg2 nh2

Thalidomide-PEG2-NH2 is a chemically synthesized E3 ligase ligand-linker conjugate consisting of a ligand derived from Thalidomide-based cereblon and a linker commonly employed in PROTAC technology.

Thalidomide-O-amido-PEG2-C2-NH2 TFA (E3 Ligase Ligand-Linker Conjugates 24 TFA) 包含基于 Thalidomide 的 cereblon 配体和 2 个单元的 PEG linker，是一种合成的 E3 连接酶配体-linker 偶联物。

Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate, combines a Thalidomide-based cereblon ligand with a two-unit PEG linker for use in PROTAC technology[1].

Thalidomide-O-amido-PEG3-C2-NH2 TFA, a synthesized E3 ligase ligand-linker conjugate, combines the cereblon ligand based on Thalidomide and a 2-unit PEG linker for use in PROTAC technology[1].

Thalidomide-O-amido-PEG3-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology[1].

Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride 包含一个 E3 连接酶配体和一个 linker。 Thalidomide-O-amido-PEG2-C2-NH2 盐酸盐可用作治疗癌症的免疫调节剂。

JB300 是一种利用PROTAC技术的Aurora A高选择性降解剂（DC50=30 nM），用于肿瘤研究。JB300 由PROTAC靶蛋白配体MK-5108 (pink part)、E3连接酶配体Thalidomide-O-COOH (blue part) 及PROTAC Linker Boc-NH-PEG2-C2-NH2 (black part) 组成，其中E3泛素连接酶配体与Linker的结合物为Thalidomide-O-COOH-NH2-C2-PEG2-NH-Boc。

Thalidomide-O-COOH-NH2-C2-PEG2-NH-Boc 是一种包含 E3 连接酶配体和连接子的偶联物，结合了基于 Thalidomide 的 CEREBLON 配体和一个 PEG linker。此化合物可以用于合成 PROTAC 降解剂 JB300。

Thalidomide-O-amido-PEG2-C2-NH2, which combines an E3 ligase ligand with a linker, serves as an immunomodulator for cancer treatment.

Thalidomide-Piperazine-PEG2-NH2 is a synthetic E3 ligase ligand-linker conjugate that combines the cereblon ligand derived from Thalidomide with a linker commonly utilized in PROTAC technology.

Thalidomide-amido-PEG2-NH2 is a synthetic conjugate of an E3 ligase ligand-linker that combines the Thalidomide-based cereblon ligand with a linker commonly utilized in PROTAC technology.

Thalidomide-5-NH-PEG2-NH2 hydrochloride，为基于Thalidomide的cereblon配体，能够募集CRBN蛋白。通过linker与靶蛋白配体相连，用于形成PROTAC分子，如THAL-SNS-032。

Thalidomide-5-PEG2-NH2 hydrochloride 是Thalidomide衍生的cereblon配体，能募集CRBN蛋白。通过linker，该化合物可与靶蛋白配体结合，进而构建PROTAC分子，如THAL-SNS-032。